CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Crãƒâ©teil - Cedex, France

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

    Phase

    3

    Span

    300 weeks

    Sponsor

    Chiesi Farmaceutici S.p.A.

    Pendik

    Recruiting

  • Results of Safety Guidewire Use in Ureteroscopic Stone Surgery

    Phase

    N/A

    Span

    292 weeks

    Sponsor

    Marmara University

    Pendik

    Recruiting

  • Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    Phase

    3

    Span

    362 weeks

    Sponsor

    Eli Lilly and Company

    Pendik, İstanbul

    Recruiting

  • Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

    To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.

    Phase

    3

    Span

    365 weeks

    Sponsor

    Gilead Sciences

    Pendik

    Recruiting

1-4 of 4
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information